Medical Science

Medical Needs Are Learned on Site. Offering True Value with Our Pharmaceutical Products

Sumitomo Pharma's Medical Information Department and Medical Affairs Department work in tandem to form the Company's Medical Science framework, with the same Executive Officer responsible for both departments. Their objective is to strengthen our capability to accurately grasp the needs of healthcare professionals, patients and their families and to execute medical communication and provision of medical information to address those needs in a scientifically objective, unbiased, reliable, and evidence-based manner.
The value of pharmaceutical products is increased by additional product information and post-marketing information. For unmet medical needs in diseases for which effective therapies are yet to be found and other issues, we generate evidence that will fulfill such needs for both healthcare professionals and patients and provide it to healthcare professionals. The evidence data generated is one of the appropriate criteria for treatment options and has benefits for both healthcare professionals and patients.
Through the provision of high quality medical and scientific information concerning our products to healthcare professionals, Medical Affairs Department strives to maximize product value and promote proper use. In addition, our Medical Science Liaisons (MSLs) work to ascertain unmet medical needs through interactive scientific communication with healthcare professionals, which will lead to new evidence generation, additional dosage forms, and additional indications. MSLs also serve as contact persons for clinical and non-clinical research and provide medical information based on advanced scientific knowledge in response to requests from healthcare professionals.

Medical Needs Are Learned on Site. Offering True Value with Our Pharmaceutical Products

In fiscal 2021, we pursued activities to generate new evidence in relation to psychiatry and neurology as well as diabetes. The evidence we generated have been shared with healthcare professionals through presentation at academic conferences and publication in journals.

The achievement of the United Nations' Sustainable Development Goals ("SDGs") requires a system which enables governments and other decision makers in all parts of the world to access the necessary resources, and focus their efforts on science, technology, and innovation. We believe that we can contribute to the attainment of SDGs by publishing our research findings as much as possible in the form of openly accessible academic papers. Going forward, we plan to set up a dedicated medical affairs website for healthcare professionals, and post information on our academic papers there.

Promoting Appropriate Provision of Product Information Based on Scientific Evidence

Medical Information Department produces materials for the proper use of our pharmaceutical products to healthcare professionals, by creating such information on our products and supporting the provision of such information to healthcare professionals by Medical Representatives (MRs).
We also provide documents such as "Kusuri-no-shiori," (drug information sheets) and "Instructional Leaflets" describing how to take medicines and specific symptoms of possible adverse reactions, which are used by healthcare professionals in explaining to patients. In addition, the "Instructional Leaflets" use illustrations so that the elderly and child patients can easily understand their explanations.
In order to be able to offer 24-hour support for regional healthcare, we will utilize our websites and other methods, and continue to provide and communicate easy-to-understand information to patients and their families, while addressing the on-site needs of medical institutions.

Product Information System "DI-SaGaS"

The efficacy of pharmaceutical products will be manifested when they are used based on product information concerning efficacy and safety. We believe that the prompt and accurate provision of product information will raise the value of our products for our customers. In addition to making information available on websites, we utilize a unique product information search system (DI-SaGaS) to respond to inquiries from healthcare professionals to our MRs and the Product Information Center.
As there is a growing demand for pharmaceutical safety information, we will continue to review and enhance the content of our system to make sure that it meets their needs. We will also strive to provide information that is more trustworthy and leads to even greater customer satisfaction.

Product Information System DI-SaGaS

Act as an Information Hub Further Utilizing Customer Feedback

We established the Product Information Center within our Medical Information Department as a hub which provides information on our products and handles inquiries concerning our products we receive from patients and their families, as well as healthcare professionals.
We will continue to contribute to the health of patients by providing information on proper use of pharmaceuticals in a prompt, accurate, and courteous manner. We will strengthen our role in making improvements, such as by analyzing the inquiries received, visualizing the trends in inquiries, and feeding back internally as appropriate.

Total number of inquiries in fiscal 2021 (April 1, 2021 - March 31, 2022): Around 34,000

Click here (ESG Data Table under Information Related to ESG) for more details on the Product Information Center including total numbers of inquiries received.
As a research and development-oriented pharmaceutical company with a global presence, Sumitomo Pharma aims to continuously create innovative, effective medicines in areas with high unmet medical needs. Through the provision of high quality information on our products created in our Medical Science framework, we will make efforts to further enhance our contribution to healthcare professionals and the health of patients.